News

These agreements stop all current litigation between the two parties in the fields of interventional cardiology and endovascular repair. All the disputes involved intellectual property. The stand-down agreements

Data obtained from animal studies have demonstrated that Ampakine compounds can specifically stimulate breathing by activating regions in the brain stem. In 2008, Cortex announced positive results of

“As previously announced, reduced demand in our Early Development segment from a combination of a lower level of new project initiations and increased project delays in our toxicology

Besides its lead drug, Ketotransdel (a topical nonsteroidal antiinflammatory drug currently in a Phase III trial for acute pain), the company is exploring potential co-development opportunities with corporate

GeoPharma receives $2.5 million in cash and notes and will maintain 40% ownership in the business under the terms of the agreement. GeoPharma hopes that the formation of

The company has reported net earnings of $1.53 billion for the fourth quarter of 2008, an increase of 28%, compared to $1.20 billion posted in the fourth quarter

James S. Kuo, Cordex’s chief executive officer commented, “We are pleased to have completed our corporate name change and selected a new ticker symbol. The Cordex name was

James Kelly, CEO of Stem Cell Innovations, said: “We have been working for several years to develop a more effective method for producing stem cells from germ cells.

Ethox produces proprietary medical devices and is engaged in contract manufacturing of disposables for many medical device companies. Ethox also provides microbiology, toxicology and sterilization services. In 2006,